Carillo, Gabriel C.

HRN: 21-87-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2022
CLOXACILLIN 500MG (CAP)
09/12/2022
09/21/2022
ORAL
500mg
Qid
CAP MR Covid 19 Pneumonia Severe
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Choice  Wrong Dose

Overall appropriateness: No  Wrong Choice

Intervention



Type of Intervention done:

                    

           


Acceptance: